Elite Pharmaceuticals ELTP
OTC ELTP
$0.25 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Elite Pharmaceuticals (ELTP) Accounts Payables (2011 - 2026)

Updated

Elite Pharmaceuticals (ELTP) posted Accounts Payables of $5.59 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 9.9% from $5.09 million a year earlier but down 7.6% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Accounts Payables (2011 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Accounts Payables came in at $6.05 million, up 104.7% from FY2025.

  • Annual Accounts Payables has increased for five consecutive fiscal years, with a five-year compound annual growth rate of 45.5% (FY2021 to FY2026).
  • In prior fiscal years, Elite Pharmaceuticals' Accounts Payables was $2.96 million in FY2025 (+9.0%), $2.71 million in FY2024 (+10.9%), $2.45 million in FY2023 (+71.0%) and $1.43 million in FY2022 (+53.9%).
  • Quarterly Accounts Payables has run from a low of $1.28 million in fiscal Q3 2022 to a high of $6.52 million in fiscal Q3 2026 over five years.
  • On a year-over-year basis, Accounts Payables has increased in each of the last seven quarters, with growth averaging 45.0% over the last eight quarters.
  • The strongest year-over-year quarter for Accounts Payables in the past five years was fiscal Q2 2022, with growth of 203.7%; the weakest was fiscal Q2 2025, with a decline of 45.0%.
  • According to Business Quant data, Accounts Payables for the three prior fiscal quarters was $6.05 million (Q4 2026), $6.52 million (Q3 2026) and $3.42 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 9.22 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 33.30 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 3.83 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 22.89 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 674.00 Mn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 4.58 Bn
10 Elite Pharmaceuticals 258.43 Mn 140.10 Mn 13.51 Mn 5.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.59 Mn
Mar 31, 2026 6.05 Mn
Dec 31, 2025 6.52 Mn
Sep 30, 2025 3.42 Mn
Jun 30, 2025 5.09 Mn
Mar 31, 2025 2.96 Mn
Dec 31, 2024 5.84 Mn
Sep 30, 2024 1.98 Mn
Jun 30, 2024 2.61 Mn
Mar 31, 2024 2.71 Mn
Dec 31, 2023 2.89 Mn
Sep 30, 2023 3.61 Mn
Jun 30, 2023 1.87 Mn
Mar 31, 2023 2.45 Mn
Dec 31, 2022 1.47 Mn
Sep 30, 2022 1.72 Mn
Mar 31, 2022 1.43 Mn
Dec 31, 2021 1.28 Mn
Sep 30, 2021 1.79 Mn
Jun 30, 2021 2.05 Mn
API Access

Elite Pharmaceuticals Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=ELTP&period=max&api_key=YOUR_API_KEY